News coverage about Health Insurance Innovations (NASDAQ:HIIQ) has trended somewhat positive this week, Accern reports. The research group scores the sentiment of media coverage by reviewing more than twenty million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Health Insurance Innovations earned a news sentiment score of 0.15 on Accern’s scale. Accern also gave media stories about the financial services provider an impact score of 43.625560877461 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the near term.
These are some of the media stories that may have impacted Accern Sentiment’s analysis:
Health Insurance Innovations (NASDAQ:HIIQ) opened at $27.50 on Monday. The firm has a market capitalization of $454.92, a price-to-earnings ratio of 22.54 and a beta of 0.65. Health Insurance Innovations has a 12 month low of $12.65 and a 12 month high of $37.38.
Health Insurance Innovations (NASDAQ:HIIQ) last released its quarterly earnings data on Wednesday, November 1st. The financial services provider reported $0.46 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.35 by $0.11. Health Insurance Innovations had a return on equity of 21.32% and a net margin of 5.98%. The company had revenue of $63.34 million for the quarter, compared to analyst estimates of $59.30 million. During the same quarter in the previous year, the company posted $0.33 earnings per share. The firm’s revenue for the quarter was up 37.4% compared to the same quarter last year. research analysts anticipate that Health Insurance Innovations will post 1.39 earnings per share for the current fiscal year.
Health Insurance Innovations declared that its Board of Directors has approved a stock buyback plan on Monday, October 16th that allows the company to repurchase $50.00 million in outstanding shares. This repurchase authorization allows the financial services provider to buy shares of its stock through open market purchases. Shares repurchase plans are generally an indication that the company’s leadership believes its stock is undervalued.
A number of research firms have weighed in on HIIQ. Northland Securities reissued a “buy” rating and set a $37.00 price objective on shares of Health Insurance Innovations in a research note on Tuesday, October 17th. Canaccord Genuity reissued a “buy” rating and set a $39.00 price objective on shares of Health Insurance Innovations in a research note on Monday, October 16th. Zacks Investment Research raised Health Insurance Innovations from a “hold” rating to a “strong-buy” rating and set a $24.00 price objective on the stock in a research note on Tuesday, October 17th. ValuEngine lowered Health Insurance Innovations from a “buy” rating to a “hold” rating in a research note on Wednesday, January 3rd. Finally, BidaskClub raised Health Insurance Innovations from a “hold” rating to a “buy” rating in a research note on Friday, December 15th. Two analysts have rated the stock with a hold rating, seven have issued a buy rating and one has assigned a strong buy rating to the company. The company currently has a consensus rating of “Buy” and an average price target of $32.67.
In other Health Insurance Innovations news, Director Robert S. Murley purchased 5,000 shares of the firm’s stock in a transaction dated Friday, December 8th. The shares were acquired at an average price of $22.50 per share, with a total value of $112,500.00. Following the purchase, the director now directly owns 39,734 shares in the company, valued at approximately $894,015. The purchase was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, insider Sheldon Wang sold 10,000 shares of the company’s stock in a transaction on Tuesday, December 19th. The shares were sold at an average price of $26.30, for a total value of $263,000.00. Following the completion of the transaction, the insider now directly owns 169,001 shares in the company, valued at approximately $4,444,726.30. The disclosure for this sale can be found here. In the last ninety days, insiders sold 57,464 shares of company stock worth $1,463,600. Corporate insiders own 30.00% of the company’s stock.
COPYRIGHT VIOLATION WARNING: “Health Insurance Innovations (HIIQ) Earning Somewhat Positive Press Coverage, Study Finds” was first posted by Equities Focus and is the property of of Equities Focus. If you are viewing this story on another website, it was copied illegally and republished in violation of United States & international copyright & trademark law. The original version of this story can be accessed at https://www.equitiesfocus.com/2018/01/08/health-insurance-innovations-hiiq-earning-somewhat-positive-press-coverage-study-finds.html.
About Health Insurance Innovations
Health Insurance Innovations, Inc is a developer, distributor and cloud-based administrator of individual and family health insurance plans (IFPs) and supplemental products, which include short-term medical (STM) insurance plans, and guaranteed-issue and underwritten hospital indemnity plans. The Company also develops, distributes and administers supplemental products, which include a range of additional insurance and non-insurance products, such as pharmacy benefit cards, dental plans, vision plans, cancer/critical illness plans, deductible and gap protection plans, and life insurance policies that are purchased as supplements to IFP.
Receive News & Ratings for Health Insurance Innovations Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Health Insurance Innovations and related companies with MarketBeat.com's FREE daily email newsletter.